Human Immune Monitoring Center

Icahn School of Medicine at Mount Sinai

33180 Citations
83 h-index
364 Article
35 Review article
21 Comment/debate
8 Chapter
More

A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0
Gulati, N., Block, B. R., Mehta, J. & Marron, T. U., 16 Jul 2026, In: JAMA Oncology. 12, 7, p. 689-690 2 p.
Research output: Contribution to journal › Short survey › peer-review
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma
Lombardi, P., Ramon-Gil, E., Raja, R. Q., Brunetti, L., Manfredi, G. F., Zhou, Z., Merces, G., Cappuyns, S., Maria Fulgenzi, C. A., D’Alessio, A., Torkpour, A., Celsa, C., Stefanini, B., Yang, H., Crowley, F., Marron, T. U., Saeed, A., Pinter, M., Scheiner, B. & Huang, Y. H. & 35 others, Lee, P. C., Nishida, N., Po-Ting Lin, R., Dalbeni, A., Vivaldi, C., Masi, G., Rohlen, N., von Felden, J., Kaseb, A., Galle, P. R., Kudo, M., Hsu, W. F., Rimassa, L., Parisi, A., Kelley, R. K., Toyoda, H., Pirisi, M., Jabar, F., Rakaee, M., Cabibbo, G., Cammà, C., Piscaglia, F., Hwang, S., Shin, D. J., Li, M., Dekervel, J., Guerra, N., Meyer, T., Reeves, H. L., Bengsch, B., Daniele, G., Mann, D. A., Chon, H. J., Leslie, J. & Pinato, D. J., 2026, (Accepted/In press) In: Journal of Hepatology.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Approximating Molecular Sepsis Subtypes Using Bedside Data in Resource-Limited Settings: A Multicenter Analysis From Uganda
Bakamutumaho, B., Lutwama, J. J., Owor, N., Lu, X., Eliku, P. J., Namulondo, J., Kayiwa, J., Ross, J. E., Nsereko, C., Nsubuga, J. B., Shinyale, J., Asasira, I., Kiyingi, T., Reynolds, S. J., Nie, K., Kim-Schulze, S. & Cummings, M. J., Aug 2026, In: Critical Care Explorations. 8, 8, e1463.
Research output: Contribution to journal › Article › peer-review

Open Access
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
Immune Atlas Consortium, Jan 2026, In: Nature Cancer. 7, 1, p. 224-246 23 p.
Research output: Contribution to journal › Article › peer-review

Open Access
10 Scopus citations
A Tumor-Promoting Inflammatory SPP1⁺ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
Tran, M. A., Cho, B. A., Izadmehr, S., Yoo, S. K., Youssef, D., Anker, J. F., Farkas, A. M., Figueiredo, I., Lee, K., Ananthanarayanan, A., Balan, S., Onkar, S., Banchereau, R., Gupta, S., Chhibber, A., Wang, L., Beaumont, K. G., Li, Z., Garcia-Barros, M. & Bicak, M. & 18 others, Cordon-Cardo, C., Brody, R., Kim-Schulze, S., Yuen, K., Mariathasan, S., Atiq, S. O., Adeyelu, T. T., Elliott, A., Barata, P., McKay, R. R., Gnjatic, S., Gonzalez-Kozlova, E., Mehrazin, R., Horowitz, A., Sfakianos, J. P., Chowell, D., Galsky, M. D. & Bhardwaj, N., Jun 2026, In: Cancer Discovery. 16, 6, p. 1126-1151 26 p.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Author Correction: Innovative approaches for lung cancer screening and interception (Nature Reviews Clinical Oncology, (2026), 10.1038/s41571-026-01131-4)
Zhang, J., Park, M. D., Pandya, T., Shum, E., Wu, J., Heeke, S., Salehi-Rad, R., Marron, T. U., Wei, Z., Li, H., Blum, T. G., Heymach, J. V., Dubinett, S. M., Yang, P. C., Swanton, C. & Merad, M., May 2026, In: Nature Reviews Clinical Oncology. 23, 5, p. 390 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors (Communications Medicine, (2026), 6, 1, (1), 10.1038/s43856-025-01230-w)
IMPACC Network, Dec 2026, In: Communications Medicine. 6, 1, 125.
Research output: Contribution to journal › Comment/debate

Open Access
CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis
Witzleben, A. V., Remark, R., Idel, C., Ribbat-Idel, J., Krupar, R., Schröck, A., Klümper, N., Doescher, J., Sikora, A. G., Kors, T. A., Vahl, J. M., Brand, M., Sonntag, M., Brunner, C., Hoffmann, T. K., Perner, S., Gnjatic, S. & Laban, S., Jun 2026, In: Translational Oncology. 68, 102776.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Could a COVID-19 vaccine improve the effectiveness of cancer immunotherapy?
Gnjatic, S., Feb 2026, In: Nature Reviews Clinical Oncology. 23, 2, p. 90-91 2 p.
Research output: Contribution to journal › Comment/debate
1 Scopus citations
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials
Fumet, J. D., Dugage, M. R., Danlos, F. X., Hueso, T., Pinato, D. J., Luke, J., Bermejo, I. M., Lorusso, P., Brody, J., Harrington, K., Segal, N. H., Diab, A., Garralda, E., Marron, T., Houot, R., Champiat, S. & Marabelle, A., Jul 2026, In: Annals of Oncology. 37, 7, p. 892-901 10 p.
Research output: Contribution to journal › Review article › peer-review
Decoupling of maternal and neonatal inflammatory levels at the maternal-fetal interface: evidence from a population-based proteomic study
Milazzo, F., Gigase, F., Suleri, A., Amreen, B., D’Souza, D., Kim-Schulze, S., Bergink, V., de Witte, L., Lesseur, C. & Rommel, A. S., 2026, In: Frontiers in Immunology. 17, 1715880.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study
Adib, E., Nassar, A. H., Lee, K. N., Fusco, F., Crowley, F., Baena, J., Worth, J. E., Abi Jaoude, J., Addeo, A., Bou Farhat, E., Rakaee, M., Amini, A., Lambden, J., Rost, M., Bolnykh, I., Aboubakar Nana, F., Aujayeb, A., Cortellini, A., Newsom-Davis, T. & Camidge, D. R. & 9 others, Vitzthum, L. K., Cappuzzo, F., Marron, T. U., Lanuti, M., Gainor, J. F., Kwiatkowski, D. J., Park, H. S., Owen, D. & Keane, F. K., Apr 2026, In: JTO Clinical and Research Reports. 7, 4, 100949.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations

Researchers from Icahn School of Medicine at Mount Sinai Describe Findings in COVID-19 (Impact of Gestational Maternal SARS-CoV-2 Infection on Neonatal Inflammatory Biomarkers)
Kim-Schulze, S., D'Souza, D., Chen, J., Rommel, A., De Witte, L., Lesseur, C. & Bergink, V.
3/09/26
1 item of Media coverage
Press/Media
Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging
Merad, M., Nestler, E. J., Walker, R., Marron, T., Carr, B., Fayad, Z. & Elahi, F.
26/08/26
1 item of Media coverage
Press/Media
Which Anti-Aging Ideas Actually Work? XPrize Healthspan Is Testing The Best Longevity Innovations
Merad, M. & Marron, T.
21/08/26
7 items of Media coverage
Press/Media
Investigators from Icahn School of Medicine at Mount Sinai Target Cancer (Dendritic Cells Control Tertiary Lymphoid Structure Development and Maintenance In Cancer)
Merad, M., Lujambio, A., Kim-Schulze, S., D'Souza, D., Hamon, P., Polydorides, A. D., Brown, B., Marron, T., Schotsaert, M., Gnjatic, S., Brody, J., Kamphorst, A. O., Lujambio Goizueta, A., Bhardwaj, N., Chen, Z., Mestrallet, G. & Donne, R.
17/08/26
1 item of Media coverage
Press/Media
Mount Sinai Advances As Milestone 2 Awardee In XPRIZE Healthspan, A $101 Million Global Competition Focused On Extending Healthy Aging
Merad, M., Nestler, E. J., Walker, R., Marron, T., Carr, B., Fayad, Z. & Elahi, F.
11/08/26 → 12/08/26
8 items of Media coverage
Press/Media
Mount Sinai Reaches Milestone 2 in $101 Million XPRIZE Healthspan Competition
Merad, M., Nestler, E. J., Walker, R., Marron, T., Carr, B., Fayad, Z. & Elahi, F.
12/08/26
2 items of Media coverage
Press/Media
Reports Summarize Information Technology Findings from Harbin Institute of Technology (ComicGTN infers disease-associated rare cell states from single-cell multiomic data using DNA sequence-augmented graph transformer networks)
Qi, J.
5/08/26
1 item of Media coverage
Press/Media
Pheast Therapeutics to Host Educational KOL Webinar on Emerging Role of Macrophage Checkpoint Biology for the Treatment of Solid Tumors
Marron, T.
3/08/26 → 4/08/26
11 items of Media coverage
Press/Media
Center to uncover reasons behind peanut allergy treatment success
Bunyavanich, S., Sicherer, S. & Wambre, E.
28/07/26
1 item of Media coverage
Press/Media
Study Results from Icahn School of Medicine at Mount Sinai Broaden Understanding of Urothelial Cancer (Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A ...)
Izadmehr, S., Nie, K., Mehrazin,, R., Xie, H., Kelly, G. & Brody, R.
24/07/26
1 item of Media coverage
Press/Media
Mount Sinai gets $7.2M NIH grant for precision peanut allergy treatment
Wang, P., Bunyavanich, S., Sicherer, S. & Wambre, E.
7/07/26
1 item of Media coverage
Press/Media
Mount Sinai Receives $7.2 Million NIH Grant to Advance Precision Medicine for Peanut Allergy Treatment
Wang, P., Bunyavanich, S., Sicherer, S. & Wambre, E.
7/07/26
3 items of Media coverage
Press/Media

Human Immune Monitoring Center

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Zhihong Chen

Darwin D'Souza

Sacha Gnjatic

Geoffrey Kelly

Seunghee Kim-Schulze

Thomas Marron

Kai Nie

Jingjing Qi

Erik Wambre

Hui Xie

A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma

Approximating Molecular Sepsis Subtypes Using Bedside Data in Resource-Limited Settings: A Multicenter Analysis From Uganda

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma

A Tumor-Promoting Inflammatory SPP1⁺ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer

Author Correction: Innovative approaches for lung cancer screening and interception (Nature Reviews Clinical Oncology, (2026), 10.1038/s41571-026-01131-4)

Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors (Communications Medicine, (2026), 6, 1, (1), 10.1038/s43856-025-01230-w)

CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis

Could a COVID-19 vaccine improve the effectiveness of cancer immunotherapy?

Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials

Decoupling of maternal and neonatal inflammatory levels at the maternal-fetal interface: evidence from a population-based proteomic study

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study

Researchers from Icahn School of Medicine at Mount Sinai Describe Findings in COVID-19 (Impact of Gestational Maternal SARS-CoV-2 Infection on Neonatal Inflammatory Biomarkers)

Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging

Which Anti-Aging Ideas Actually Work? XPrize Healthspan Is Testing The Best Longevity Innovations

Investigators from Icahn School of Medicine at Mount Sinai Target Cancer (Dendritic Cells Control Tertiary Lymphoid Structure Development and Maintenance In Cancer)

Mount Sinai Advances As Milestone 2 Awardee In XPRIZE Healthspan, A $101 Million Global Competition Focused On Extending Healthy Aging

Mount Sinai Reaches Milestone 2 in $101 Million XPRIZE Healthspan Competition

Reports Summarize Information Technology Findings from Harbin Institute of Technology (ComicGTN infers disease-associated rare cell states from single-cell multiomic data using DNA sequence-augmented graph transformer networks)

Pheast Therapeutics to Host Educational KOL Webinar on Emerging Role of Macrophage Checkpoint Biology for the Treatment of Solid Tumors

Center to uncover reasons behind peanut allergy treatment success

Study Results from Icahn School of Medicine at Mount Sinai Broaden Understanding of Urothelial Cancer (Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A ...)

Mount Sinai gets $7.2M NIH grant for precision peanut allergy treatment

Mount Sinai Receives $7.2 Million NIH Grant to Advance Precision Medicine for Peanut Allergy Treatment

Human Immune Monitoring Center

Fingerprint

Collaborations and top research areas from the last five years

Profiles

Research output

Press/Media